About this collection
A new era in T1D management
This educational program provides the essential framework to transform T1D into a more predictable and manageable condition for your patients, with opportunity for proactive support measures or care.
Identify risk, prevent crisis
Grasp the new understanding of T1D as a staged autoimmune disease. By using simple screening to identify individuals in the long pre-symptomatic phase, you can prevent the trauma of DKA and shift families from an emergency response to a planned, supported healthcare journey.
A clinical framework for action
This program delivers more than theory. You will gain the clinical tools to act, including the new international consensus guidelines for monitoring, which were recently released – with several steering committee members contributing. You will also learn about the application of disease modifying therapies, such as teplizumab (currently approved in select countries such as the US and Canada), that can help to delay disease progression, preserve beta-cell function, and provide a better quality of life for your patients.
Let's change the landscape of T1D.
WEBINAR FOR GENERAL PRACTICE - inc. live Q&A
Wednesday 15 April 2026, 7:30-9:00pm AEST
Description:
Early stage type 1 diabetes (T1D) is a critical yet poorly understood phase preceding clinical diagnosis. With 90% of diagnoses occurring without a family history, many individuals progress silently through islet autoimmunity until presenting with life-threatening diabetic ketoacidosis (DKA).
This webinar provides a case-based approach to navigating the GP's role in early identification and shared care. Using a single case study followed across key decision points, clinical experts will guide you through pre-test counselling, interpreting islet autoantibodies, and applying the international three-stage framework. You will learn to identify high-risk phenotypes, establish evidence-based monitoring cadences, and recognise urgent "red flags" for specialist referral. The session also explores emerging disease-modifying therapies and practical strategies to reduce diagnostic delay, equipping you to support families with clarity and confidence.
Learning outcomes:
-
Apply a structured GP approach to early stage T1D across key clinical decision points to guide when to test, how to counsel, and when to refer.
-
Interpret autoantibody and baseline glycaemic results in context, recognising which findings require routine referral, urgent escalation, or ongoing shared care, and avoiding common management gaps after results are returned.
-
Support patients and families once specialist care is established, including communicating risk, managing uncertainty and anxiety, and responding appropriately to questions and concerns.
Presenters:
Dr Sarah Black
Endocrinologist
Dr Richard Liu
Endocrinologist
Dr Anita Sharma
GP and Medical Educator
Now available free & on-demand
Description:
General practitioners play a vital role in addressing the alarming reality that one-third of Australian children first present with life-threatening diabetic ketoacidosis, while many adults endure prolonged metabolic decompensation due to frequent misdiagnosis as having type 2 diabetes.
By engaging with this education, you will learn to accurately classify patients using the international three-stage framework, implement proactive shared-care monitoring plans that recognise urgent red flags, and utilise person-first communication strategies to effectively support families facing the significant psychosocial burden of a type 1 diabetes risk identification.
Learning outcomes:
-
Identify individuals at increased risk of T1D and determine when islet autoantibody testing is clinically indicated.
-
Apply the internationally recognised staging framework for early-stage T1D (Stages 1–3) to support accurate classification and timely action.
-
Develop and implement an appropriate monitoring and referral plan for children and adults with islet autoimmunity.
-
Communicate risk and uncertainty clearly to individuals and families to support preparedness and psychosocial wellbeing.
Dr Sarah Black
Endocrinologist
Dr Richard Liu
Endocrinologist
Dr Anita Sharma
GP and Medical Educator
Patient handout kits coming soon...
To support clinicians' consultations with patients, families and carers on pre-T1D diagnosis, Breakthrough T1D is currently developing a range of online resources.
To receive updates on when these resources become available, pre-register here.
Steering committee
Continuing Professional Development (CPD) Details
This medical education collection is being developed to Australian medical CPD standards and will offer learners a combination of Educational Activity, Reviewing Performance and Measuring Outcomes education.
See individuial activities for relevant accreditation details.
Certificates of completion will be available to learners upon successful completion of each activity.
.webp)
Praxhub is an accredited Major Provider under the RACGP CPD Program.
Praxhub would like to acknowledge Breakthrough T1D (Formerly JDRF) for its support of this education.
Register your interest in this T1D education
This groundbreaking education is coming very soon. Be the first to hear about it when it does! By registering your interest below we'll let you know as soon as it's available in Praxhub.
Unless additional consent is granted, the details provided by you will only be used for the purpose of notifying you when these activities and resources become available. If you have questions regarding the collection or use of your information, please contact privacy@praxhub.com.
References:
1. Breakthrough T1D, https://breakthrought1d.org.au/what-is-t1d/quick-guide-to-t1d/